Patients with CKD exhibit a disproportionate burden of cardiovascular mortality, which likely
stems from the presence of unique, nontraditional risk factors that accompany deteriorating …

The recent explosion of scientific interest in the gut microbiota has dramatically advanced
our understanding of the complex pathophysiological interactions between the gut and …

In chronic kidney disease (CKD), cardiovascular (CV) damage is present in parallel which
leads to an increased risk of CV disease. Both traditional and non-traditional risk factors …

Survival outcomes of patients with end stage renal disease are worse than those of many
metastatic cancers. Kidney disease patients are often inflicted with higher rates of …

Cardiovascular disease (CVD) is the leading cause of death worldwide. The human body is
populated by a diverse community of microbes, dominated by bacteria, but also including …

Chronic kidney disease (CKD) is estimated to affect nearly 500 million people worldwide
and cardiovascular (CV) disease is a major cause of death in this population. However …

The human gut harbors> 100 trillion microbial cells, which influence the nutrition,
metabolism, physiology, and immune function of the host. Here, we review the quantitative …

The rapid expansion of microbiota research has significantly advanced our understanding of
the complex interactions between gut microbiota and cardiovascular, metabolic, and renal …

With over 100 trillion microbial cells, the gut microbiome plays important roles in both the
maintenance of health and the pathogenesis of disease. Gut microbiome dysbiosis, resulted …

Chronic kidney disease (CKD) is an increasing global health burden. Current treatments for
CKD include therapeutics to target factors that contribute to CKD progression, including …